Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
PLA D
ID: ALA1242564
Max Phase: Preclinical
Molecular Formula: C30H50O9
Molecular Weight: 554.72
Molecule Type: Small molecule
Associated Items:
ID: ALA1242564
Max Phase: Preclinical
Molecular Formula: C30H50O9
Molecular Weight: 554.72
Molecule Type: Small molecule
Associated Items:
Synonyms (1): Pladienolides D
Synonyms from Alternative Forms(1):
Canonical SMILES: CC[C@H](O)[C@@H](C)[C@H]1O[C@@H]1C[C@@](C)(O)/C=C/C=C(\C)[C@H]1OC(=O)C[C@H](O)CC[C@@](C)(O)[C@@H](OC(C)=O)CC[C@@H]1C
Standard InChI: InChI=1S/C30H50O9/c1-8-23(33)20(4)28-24(38-28)17-29(6,35)14-9-10-18(2)27-19(3)11-12-25(37-21(5)31)30(7,36)15-13-22(32)16-26(34)39-27/h9-10,14,19-20,22-25,27-28,32-33,35-36H,8,11-13,15-17H2,1-7H3/b14-9+,18-10+/t19-,20+,22+,23-,24+,25-,27+,28+,29-,30+/m0/s1
Standard InChI Key: XNQFVAOONHSTGY-ZRQGREGYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 554.72 | Molecular Weight (Monoisotopic): 554.3455 | AlogP: 3.36 | #Rotatable Bonds: 9 |
Polar Surface Area: 146.05 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 13.85 | CX Basic pKa: | CX LogP: 2.41 | CX LogD: 2.41 |
Aromatic Rings: 0 | Heavy Atoms: 39 | QED Weighted: 0.19 | Np Likeness Score: 2.50 |
1. Kotake Y, Sagane K, Owa T, Mimori-Kiyosue Y, Shimizu H, Uesugi M, Ishihama Y, Iwata M, Mizui Y.. (2007) Splicing factor SF3b as a target of the antitumor natural product pladienolide., 3 (9): [PMID:17643112] [10.1038/nchembio.2007.16] |
Source(1):